Anthrax Treatment Approach Tested in Mice May Overcome "Point Of No Return" University of Pittsburgh results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.
Genetic Engineering & Biotechnology News
图书期刊出版业
New Rochelle，New York 181,125 位关注者
The Bedrock of Biotech
关于我们
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- 网站
-
https://www.genengnews.com
Genetic Engineering & Biotechnology News的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 51-200 人
- 总部
- New Rochelle，New York
- 类型
- 私人持股
- 创立
- 1981
- 领域
- Biotechnology、Drug Discovery、Bioprocessing、Translational Medicine、OMICS和Genome Editing
地点
-
主要
获取路线
140 Huguenot St
US，New York，New Rochelle，10801
Genetic Engineering & Biotechnology News员工
动态
-
GLP-1 Drugs Effectiveness Reduced by Neurons That Control Overeating UC San Diego researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating. #GLP1 #obesity
-
Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary CRISPR leaders across the Innovative Genomics Institute ecosystem, which spans multiple California institutes and hospitals including University of California, San Francisco, UCSF Benioff Children's Hospitals, and UCLA, came together to change the tone by celebrating the one-year anniversary. Fay Lin, PhD, provides the details. #CRISPR #GenomeEditing Jennifer Doudna
-
DON'T MISS OUT! Successful Scale-Up of an Upstream Viral Vector Process Using an Adherent Platform In this March 31st webinar, you’ll get an in-depth look at a case study of a helper-dependent adenovirus (HDAd) process from bench scale and optimization, to a successful scale-up and tech transfer using adherent culture. Register now to join us for this free webinar sponsored by Cytiva: https://hubs.li/Q03bQqw40 Brian Gardell #GeneTherapies
-
-
Experts Discuss Guardrails for Heritable Human Genome Editing Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient advocates, in Washington, DC, this week to review the current state of HHGE guidelines and policies, with particular emphasis on the risks, benefits, and potential guard rails. Alliance for Regenerative Medicine, American Society of Gene & Cell Therapy, ISCT, International Society for Cell & Gene Therapy
-
Weill Cancer Hub East Established with $50 Million Gift from the Weill Family The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact #cancer progression and treatment. Princeton University, The Rockefeller University, Weill Cornell Medicine, Ludwig Cancer Research #NYC
-
Tools Designed to Develop African Swine Fever Virus Vaccines More Efficiently A recent study estimates if ASFV reached the United States it could result in economic losses exceeding $50 billion over a ten-year period. J. Craig Venter Institute, Friedrich-Loeffler-Institut, International Livestock Research Institute (ILRI) #SwineFlu
-
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder. #epigentic #MuscularDystrophy
-
Life Sciences AI and Compliance: Trust But Rigorously Verify The increased adoption of AI technologies also invites unique regulatory compliance risks stemming from the growing automation of certain business functions. Don't miss the guest commentary by Gejaa Gobena, Emily Lyons, and Jesse Suh from the Hogan Lovells law firm. https://hubs.li/Q03dFcSZ0
-
DON'T MISS OUT! NGS Workflows for Expedited Development & Manufacturing of Therapeutic Antibodies In this April 2nd GEN webinar, scientists from Moderna and seqWell will present several applications of a fully scalable, streamlined NGS library preparation workflow that span antibody development and biomanufacturing. Register now to join us for this free webinar sponsored by seqWell: https://hubs.ly/Q03byK6n0 #Bioprocessing #DrugDiscovery #Omics Nasthas L. Joe Mellor
-